Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Mangalam Drugs and Organics Ltd.

NSE: MANGALAM | BSE:532637

₹108.57 2.75 (2.60%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

105.60

Today’s High

110.10

52W low

90.80

52W High

132.40

Open Price

106.00

Prev. Close

101.6500

Volume

88591.00

Value

9618324.87

Fundamentals

Market Cap Cr

171.80

Price to Earnings

-19.00

Price to Book Value

1.20

Dividend Yield

0.00

PE to Growth

0.00

Op Revenue TTM Cr

368.59

Net Profit TTM Cr

-9.05

Cash From Operating Activity Cr

12.17

Return on Equity %

-6.35

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

106.1

10Day EMA

105.9

12Day EMA

105.9

20Day EMA

105.6

26Day EMA

105.4

50Day EMA

104.6

100Day EMA

104.4

200Day EMA

105.5

5Day SMA

105.2

10Day SMA

105.5

20Day SMA

106.5

30Day SMA

105.5

50Day SMA

103.4

100Day SMA

105.8

150Day SMA

104.4

200Day SMA

103.6

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

04 Jul, 2024

64.7

Week

57.7

Month

61.1

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

108.09

PIVOT

First Resistance

110.58

Second Resistance

112.60

Third Resistance

115.09

First Support

106.07

Second Support

103.58

Third Support

101.56

Relative Strength Index

57.03

Money Flow Index

57.97

MACD

0.53

MACD Signal

0.72

Average True Range

4.65

Average Directional Index

20.27

Rate of Change (21)

11.47

Rate of Change (125)

10.22

Commodity Channel Index

33.6

Williams %R

-58.6

BETA

1 Month

0.7

3 Month

0.57

1 Year

0.59

3 Year

0.28

PRICE CHANGE ANALYSIS

↑ 1.6%

1 Week

Low

High

101.2

110.1

↑ 7.98%

1 Month

Low

High

95

119

↑ 7.98%

3 Months

Low

High

95

127

↑ 7.18%

6 Months

Low

High

90.8

132.45

↓ -0.17%

1 Year

Low

High

90.8

132.45

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 102.28 97.34 81.58 87.49 91.40 63.46 108.33 109.50 120.96 101.88 123.02
Operating Expenses Qtr 90.53 90.36 79.36 90.94 90.86 56.86 99.89 99.12 110.76 87.57 109.26
Operating Profit Qtr 11.70 6.98 2.19 -3.47 0.24 6.47 8.43 10.38 10.20 6.27 4.94
EBIDT Qtr Cr 11.75 6.98 2.22 -3.45 0.53 6.60 8.43 10.38 10.20 14.31 13.76
Depreciation Qtr 3.86 3.62 3.73 3.42 2.75 2.88 2.76 2.60 2.69 2.67 2.50
Net Profit Qtr 3.55 0.50 -3.56 -9.54 -4.39 0.43 2.23 3.00 6.69 4.02 4.53
Basic EPS Qtr 2.24 0.32 -2.25 -6.02 -2.77 0.27 1.41 1.92 4.23 2.54 2.86
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 368.69 372.69 451.16 384.86 283.53
Operating Expenses Annual Cr 351.20 346.73 402.01 326.84 258.66
Operating Profit Annual 17.39 25.52 49.05 53.30 23.69
Operating Profit Margin Annual % 4.72 6.85 10.87 13.85 8.36
Total Expenses Annual Cr 379.75 370.47 423.42 345.34 277.28
EBIDT Annual Cr 17.49 25.95 49.14 58.02 24.87
EBIDT Annual margin % 4.74 6.96 10.89 15.08 8.77
Depreciation 14.63 10.99 10.25 9.18 8.22
PAT Before ExtraOrdinary Items Annual Cr -9.05 1.27 19.66 27.97 8.25
Net Profit Annual -9.05 1.27 19.66 27.97 8.25
Basic EPS Annual -5.72 0.80 12.42 17.67 5.21
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 142.35 151.96 150.56 130.96 103.94
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 33.85 42.32 47.75 24.25 17.26
Total Current Liabilities Annual Cr 180.95 165.36 130.11 107.64 109.47
Total Capital Plus Liabilities Annual Cr 357.14 359.63 328.43 262.85 230.67
Fixed Assets Annual 132.35 151.85 140.67 124.35 102.31
Total Non Current Assets Annual 157.36 153.04 145.96 130.87 111.49
Total Current Assets Annual 199.78 206.58 182.47 131.98 119.17
Total Assets Annual 357.14 359.63 328.43 262.85 230.67
Contingent Liabilities plus Commitments Annual Cr - 26.33 6.26 9.61 7.28
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 12.17 39.52 25.71 27.55 30.55
Cash from Investing Activity Annual -17.91 -22.17 -27.33 -31.29 -6.87
Cash from Financing Annual Activity 5.70 -16.62 2.98 2.70 -23.48
Net Cash Flow Annual - 0.73 1.36 -1.04 0.20
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 89.93 96.00 95.12 82.74 65.67
ROE Annual % -6.35 0.83 13.05 21.35 7.93
ROCE Annual % 1.62 7.70 19.61 31.47 13.74
Total Debt to Total Equity Annual 0.62 0.45 0.48 0.44 0.44
EBDIT Annual Margin % 4.74 6.97 10.89 15.26 8.80
Indicator Mar 2024 Dec 2023 Graph
Total Qtr Revenue cr 102.28 97.34
Operating Expenses Qtr 90.54 90.36
Operating Profit Qtr 11.70 6.98
EBIDT Qtr Cr 11.74 6.98
Depreciation Qtr 3.86 3.63
Net Profit Qtr 3.53 0.50
Basic EPS Qtr 2.23 0.31
Indicator Mar 2024 Mar 2022 Mar 2021 Graph
Total Revenue Annual 368.69 533.48 303.32
Operating Expenses Annual Cr 351.20 511.57 297.52
Operating Profit Annual 17.40 11.46 4.41
Operating Profit Margin Annual % 4.72 2.15 1.45
Total Expenses Annual Cr 379.77 514.95 299.75
EBIDT Annual Cr 17.49 21.91 5.81
EBIDT Annual margin % 4.75 4.11 1.91
Depreciation 14.65 1.20 0.02
PAT Before ExtraOrdinary Items Annual Cr -9.07 12.31 2.65
Net Profit Annual -9.07 12.31 2.65
Basic EPS Annual -5.73 9.20 131.86
Indicator Mar 2024 Mar 2022 Mar 2021 Graph
Total ShareHolders Funds Annual 135.79 45.48 12.91
Minority Interest Liability Annual Cr 0.00 0.01 0.01
Total Non Current Liabilities Annual Cr 33.85 6.41 0.02
Total Current Liabilities Annual Cr 163.79 70.75 34.47
Total Capital Plus Liabilities Annual Cr 333.42 122.65 47.40
Fixed Assets Annual 132.71 50.23 1.40
Total Non Current Assets Annual 157.70 57.36 7.75
Total Current Assets Annual 175.72 65.29 39.65
Total Assets Annual 333.42 122.65 47.40
Contingent Liabilities plus Commitments Annual Cr - 21.34 2.99
Indicator Mar 2024 Mar 2022 Mar 2021 Graph
Cash from Operating Activity Annual -11.07 2.46 5.58
Cash from Investing Activity Annual 0.00 -40.41 -1.21
Cash from Financing Annual Activity 0.00 42.40 -3.70
Net Cash Flow Annual - 4.45 0.67
Indicator Mar 2024 Mar 2022 Mar 2021 Graph
Book Value Per Share Annual 85.79 25.26 641.11
ROE Annual % -6.68 27.06 20.55
ROCE Annual % 1.67 39.91 44.75
Total Debt to Total Equity Annual 0.65 1.03 1.35
EBDIT Annual Margin % 4.74 4.18 1.92
Name Holding Percent Holding Id Pledged % Locked %
SHREE RASBIHARI TRADING AND INVESTMENTS PRIVATE LIMITED 6.39 75061836 19.98 0
Name Holding Percent Holding Id Pledged % Locked %
GOVARDHAN MURLIDHAR DHOOT 4.21 75061821 0 0
BRIJMOHAN MURLIDHAR DHOOT 3.57 75061822 0 0
SHWETA GOVARDHAN DHOOT 2.59 75061823 0 0
RADHIKA AJAY DHOOT 1.85 75061824 0 0
SMITA ADITYA DHOOT 1.85 75061825 0 0
RAJKUMARI RAMNIWAS DHOOT 1.74 75061826 0 0
DHOOT REKHA GOVARDHAN 0.94 75061827 0 0
AJAY RAMNIWAS DHOOT 0.88 75061828 99.5 0
DHOOT JYOTI BRIJMOHAN 0.66 75061829 0 0
ADITYA RAMNIWAS DHOOT 0.56 75061830 99.75 0
SHRI JB PHARMA PRIVATE LIMITED 16.74 75061834 0 0
SHREE KISHORIJU TRADING AND INVESTMENTS PRIVATE LIMITED 6.94 75061835 88.39 0
SHREE RASBIHARI TRADING AND INVESTMENTS PRIVATE LIMITED 6.39 75061836 19.98 0
RAJ EXPORTS PRIVATE LIMITED 1.21 75061837 0 0
Name Holding Percent Holding Id
Name Holding Percent Holding Id
Ashutosh Taparia 1.91 75061849
Jyotiprasad Taparia 1.33 75061850
HUF 1.58 75061842
Ambika Food Industries Private Limited 1.04 75061846
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Dec 21, 2017 0.5 INTERIM Dec 22, 2017 Equity Share
Sep 19, 2006 0.2 FINAL - Equity Share
Aug 30, 2005 0.2 FINAL - Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 21, 2024 Audited Results -
Mar 15, 2024 Others Inter alia to consider and approve: The proposal of Scheme of Merger.
Feb 13, 2024 Quarterly Results -
Nov 08, 2023 Quarterly Results -
Aug 10, 2023 Quarterly Results -
May 30, 2023 Audited Results -
Feb 13, 2023 Quarterly Results -
Nov 11, 2022 Quarterly Results -
Aug 05, 2022 Quarterly Results -
May 26, 2022 Audited & Quarterly Results -
Feb 04, 2022 Quarterly Results -
Nov 12, 2021 Quarterly Results -
Aug 12, 2021 Quarterly Results -
May 20, 2021 Audited Results -
Feb 11, 2021 Quarterly Results -
Nov 12, 2020 Quarterly Results -
Aug 10, 2020 Quarterly Results -
Jun 29, 2020 Audited Results -
Jan 24, 2020 Quarterly Results -
Nov 02, 2019 Quarterly Results -
Jul 26, 2019 Quarterly Results -
May 09, 2019 Audited Results -
Feb 11, 2019 Quarterly Results -
Nov 14, 2018 Quarterly Results -
Aug 14, 2018 Quarterly Results -
May 28, 2018 Audited Results -
Feb 12, 2018 Quarterly Results -
Dec 12, 2017 Interim Dividend -
Nov 20, 2017 Quarterly Results -
Aug 11, 2017 Quarterly Results -
May 08, 2017 Audited Results -
Feb 06, 2017 Quarterly Results -
Nov 10, 2016 Quarterly Results -
Aug 01, 2016 Quarterly Results -
Jun 10, 2016 Allotment of Equity Shares (Revised from 06/06/2016)
May 16, 2016 Audited Results -
Mar 30, 2016 Independent Director Meeting -
Jan 14, 2016 Quarterly Results & Others 1. To appoint the Internal Auditor of the Company for the financial year 2015-2016; 2. To appoint the Secretarial Auditor of the Company for the financial year 2015-16.
Nov 16, 2015 Allotment of Equity Shares To consider & approve the allotment of 12,00,000 Equity Shares on conversion of 12,00,000 Share Warrants which were allotted on preferential basis to Shri.JB Pharma LLP.
Oct 21, 2015 Others The Board of Directors have designated Mr. Brijmohan M Dhoot an existing Executive Director of the Company as the Non-Executive Director of the Company with immediate effect.
Sep 28, 2015 Others Allotted 26,50,000 convertible share warrants at Rs. 65/- (including premium of Rs. 55/-) to Shri JB Pharma LLP, Promoter group on preferential basis in accordance with the Chapter VII of SEBI.
Sep 04, 2015 Others 1. Board of Directors have appointed Mr. Brijmohan M Dhoot who is an existing non Executive Director. 2. Appointed Ms. Nikita Bavishi, as the whole time Company Secretary of the Company Secretary.
Aug 06, 2015 Others To consider and approve the issue of such number of Warrants or other securities convertible into equity shares or other securities convertible into equity shares on preferential basis.
Aug 04, 2015 Quarterly Results -
May 15, 2015 Audited Results -
Jan 23, 2015 Quarterly Results -
Nov 14, 2014 Quarterly Results -
Aug 12, 2014 Quarterly Results -
May 29, 2014 Audited Results -
Feb 13, 2014 Quarterly Results -
Nov 14, 2013 Quarterly Results -
Aug 13, 2013 Quarterly Results -
May 23, 2013 Audited Results -
Feb 12, 2013 Quarterly Results -
Nov 08, 2012 Quarterly Results -
Aug 13, 2012 Quarterly Results -
Jul 23, 2012 Audited Results & Dividend -
May 19, 2012 Quarterly Results -
Feb 13, 2012 Quarterly Results -
Nov 10, 2011 Quarterly Results -
Aug 12, 2011 Quarterly Results -
May 30, 2011 Audited Results & Dividend -
Feb 10, 2011 Quarterly Results -
Nov 12, 2010 Quarterly Results (Revised)
Jul 29, 2010 Quarterly Results -
May 29, 2010 Audited Results -
Jan 28, 2010 Quarterly Results -
Oct 28, 2009 Quarterly Results -
Jul 29, 2009 Quarterly Results -
Jun 18, 2009 Audited Results -
Jan 29, 2009 Quarterly Results -
Oct 24, 2008 Quarterly Results -
Jul 31, 2008 Quarterly Results -
Jun 20, 2008 Audited Results -
Jan 31, 2008 Quarterly Results -
Oct 29, 2007 Quarterly Results -
Jul 30, 2007 Quarterly Results -
Jun 29, 2007 Audited Results & Dividend -
Jan 30, 2007 Quarterly Results -
Dec 18, 2006 Increase in Authorised Capital -
Oct 30, 2006 Quarterly Results Proposal for raising of additional funds
Jul 31, 2006 Quarterly Results -
Jun 30, 2006 Accounts & Final Dividend -
Feb 16, 2006 Resignation of Directors -
Jan 27, 2006 Quarterly Results -
Oct 28, 2005 Quarterly Results -
Jul 27, 2005 Quarterly Results -
Jun 10, 2005 Dividend & Accounts -
Ex-Date Bonus Ratio Record Date
Bigul
29 Jun 2024

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Closure of Trading Window

 The trading window of the Company shall remain closed for Designated Persons (including their immediate relatives) from July 1, 2024 till expiry of forty-eight (48) hours after the declaration of Unaudited Financial Results of the Company for the period ended June 30, 2024.
Bigul
27 Jun 2024

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Change in Management

 Pursuant to Regulation 30 of SEBI (LODR)Regulations, 2015 it is hereby informed that Mr. Jayant Barde vide his resignation letter dated 27th June, 2024 has tendered his resignation from the position of Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company w.e.f closure of business hours of 6th July, 2024.
Bigul
27 Jun 2024

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

 Pursuant to Regulation 30 of LODR Regulations , 2015 it is hereby informed that, Mr. Jayant Barde vide his letter dated 27th June, 2024 has tendered his resignation from the position of Company Secretary and Compliance officer (Key Managerial Personnel) of the Company and will be relieved from the service of the Company with effect from the closure of business hours of 6th July, 2024.
Bigul
18 Jun 2024

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of Scheme Of Arrangement By Absorption

 Board meeting outcome for consideration and approval of Scheme of arrangement by absorption.
Bigul
18 Jun 2024

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

 Board of Directors at its meeting held on 18.06.2024 considered and approved the scheme of merger by Absorption
Bigul
29 May 2024

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report for the period ended 31st March, 2024.
Bigul
29 May 2024

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 28, 2024 for Shree Kishoriju Trading and Investments Pvt Ltd
Bigul
22 May 2024

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 22, 2024 for Shree Kishoriju Trading and Investments Pvt Ltd
Bigul
22 May 2024

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Copy of newspaper publication for the financial results for the period ended March 31 2024
Bigul
21 May 2024

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Appointment Of Secretarial Auditor Of The Company

 Appointment of Secretarial Auditor of the Company
See all News

FAQs

The latest market price of Mangalam Drugs and Organics Ltd. on NSE was Rs. 108.57 as of today.

The opening share price of Mangalam Drugs and Organics Ltd. was Rs. 106.00 as of today.

The 52-week high share price of Mangalam Drugs and Organics Ltd. was Rs. 132.40.

The 52 week low share price of Mangalam Drugs and Organics Ltd. was Rs. 90.80.

Mangalam Drugs and Organics Ltd. has a market cap of Rs. 171.80 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Mangalam Drugs and Organics Ltd. is 0.00. Please refer to the Fundamentals section for further details.

The operating revenue for Mangalam Drugs and Organics Ltd. in the last FY was Rs.  368.59 crore. Please refer to the Financials section for further details.

The Net Profit for Mangalam Drugs and Organics Ltd. in the last FY was Rs. -9.05 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Mangalam Drugs and Organics Ltd. was on 2017-12-21 for Rs. 0.5 per share. According to today’s share price, the dividend yield of Mangalam Drugs and Organics Ltd. stands at 0.00. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Mangalam Drugs and Organics Ltd..

Close

Let's Open Free Demat Account